Erasca (ERAS) Non-cash Items (2020 - 2026)

Erasca (ERAS) reported Non-cash Items of $28.7 million for Q1 2026, up 45.79% on a YoY basis from $19.7 million in Q1 2025, and down 53.44% quarter-over-quarter from $61.7 million in Q4 2025.

Erasca (ERAS) Non-cash Items (2020 - 2026) Analysis & Trends

Erasca has reported Non-cash Items for 7 years, with the latest figure at $28.7 million in Q1 2026.

  • For the quarter ending Q1 2026, Non-cash Items rose 45.79% year-over-year to $28.7 million; the trailing twelve-month figure through Mar 2026 stood at $28.7 million (up 45.79% YoY), and the FY2025 full-year result was $61.7 million, up 374.7% from the prior year.
  • Non-cash Items for Q1 2026 stood at $28.7 million, down from $61.7 million in the prior quarter.
  • The five-year high for Non-cash Items was $62.5 million in Q2 2023, with the low at $880000.0 in Q2 2025.
  • Historically, Non-cash Items has averaged $22.1 million across 5 years, with a median of $16.8 million in 2024.
  • Annual changes were most pronounced in 2022 — Non-cash Items soared 1513.67% — and 2025, when it plunged 94.19%.
  • Erasca's Non-cash Items stood at $18.3 million in 2022, then sank by 75.88% to $4.4 million in 2023, then soared by 194.4% to $13.0 million in 2024, then surged by 374.7% to $61.7 million in 2025, then sank by 53.44% to $28.7 million in 2026.
  • The last three Non-cash Items figures came in at $28.7 million (Q1 2026), $61.7 million (Q4 2025), and $24.4 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Erasca 4.16 Bn 3.92 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 28.71 Mn
Mar 31, 2026 28.71 Mn
Dec 31, 2025 61.66 Mn
Dec 31, 2025 61.66 Mn
Sep 30, 2025 24.44 Mn
Sep 30, 2025 24.44 Mn
Jun 30, 2025 880,000.00
Jun 30, 2025 880,000.00
Mar 31, 2025 19.69 Mn
Mar 31, 2025 19.69 Mn
Dec 31, 2024 12.99 Mn
Dec 31, 2024 12.99 Mn
Sep 30, 2024 16.77 Mn
Sep 30, 2024 16.77 Mn
Jun 30, 2024 15.16 Mn
Jun 30, 2024 15.16 Mn
Mar 31, 2024 7.53 Mn
Mar 31, 2024 7.53 Mn
Dec 31, 2023 4.41 Mn
Dec 31, 2023 4.41 Mn